MDS Life: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MDS Life
Largest movements
- Cash -€2,836
down €2,836 (-43.1%), from €6,580 to €3,744
mainly Receivables within one year (-€1,703) and Trade debts (-€1,645)
- Receivables within one year +€1,703
up €1,703 (+182%), from €936 to €2,639
of which Trade receivables: +€1,065
- Deferred charges and accrued income +€931
new in 2024: €931
- Stocks and contracts -€730
down €730 (-37.3%), from €1,959 to €1,228
- Trade debts -€1,645
down €1,645 (-58.3%), from €2,824 to €1,179
- Tax, wage and social debts +€1,419
new in 2024: €1,419
- Other debts -€444
down €444 (-11.6%), from €3,820 to €3,375
- Profit (loss) carried forward -€261
down €261 (-155%), from -€169 to -€430
- Gross operating margin +€2,038
up €2,038, from -€193 to €1,845
- Taxes +€1,419
new in 2024: €1,419
- Financial charges +€491
up €491 (+639%), from €77 to €567
- Other operating charges +€170
new in 2024: €170
- Financial income -€51
down €51 (-50.7%), from €101 to €50
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,475 | €8,543 | -€932 | -9.8% |
| Current assets | 29/58 | €9,475 | €8,543 | -€932 | -9.8% |
| Stocks and contracts in progress | 3 | €1,959 | €1,228 | -€730 | -37.3% |
| Stocks | 30/36 | €1,959 | €1,228 | -€730 | -37.3% |
| Amounts receivable within one year | 40/41 | €936 | €2,639 | +€1,703 | +182% |
| Trade receivables | 40 | €845 | €1,910 | +€1,065 | +126% |
| Other amounts receivable | 41 | €92 | €730 | +€638 | +696% |
| Cash at bank and in hand | 54/58 | €6,580 | €3,744 | -€2,836 | -43.1% |
| Deferred charges and accrued income | 490/1 | - | €931 | +€931 | |
| Total equity and liabilities | 10/49 | €9,475 | €8,543 | -€932 | -9.8% |
| Equity | 10/15 | €2,831 | €2,570 | -€261 | -9.2% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Contributions outside capital | 11 | €3,000 | €3,000 | = | 0.0% |
| Other | 1109/19 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€169 | -€430 | -€261 | -155% |
| Amounts payable | 17/49 | €6,643 | €5,973 | -€671 | -10.1% |
| Amounts payable within one year | 42/48 | €6,643 | €5,973 | -€671 | -10.1% |
| Trade debts | 44 | €2,824 | €1,179 | -€1,645 | -58.3% |
| Suppliers | 440/4 | €2,824 | €1,179 | -€1,645 | -58.3% |
| Taxes, remuneration and social security | 45 | - | €1,419 | +€1,419 | |
| Taxes | 450/3 | - | €1,419 | +€1,419 | |
| Other amounts payable | 47/48 | €3,820 | €3,375 | -€444 | -11.6% |
| Other operating charges | 640/8 | - | €170 | +€170 | |
| Gross operating margin | 9900 | -€193 | €1,845 | +€2,038 | |
| Operating profit (loss) | 9901 | -€193 | €1,675 | +€1,868 | |
| Financial income | 75/76B | €101 | €50 | -€51 | -50.7% |
| Recurring financial income | 75 | €101 | €50 | -€51 | -50.7% |
| Financial charges | 65/66B | €77 | €567 | +€491 | +639% |
| Recurring financial charges | 65 | €77 | €567 | +€491 | +639% |
| Profit (loss) for the period before taxes | 9903 | -€169 | €1,158 | +€1,326 | |
| Income taxes | 67/77 | - | €1,419 | +€1,419 | |
| Profit (loss) for the period | 9904 | -€169 | -€261 | -€93 | -55.0% |
| Profit (loss) for the period to be appropriated | 9905 | -€169 | -€261 | -€93 | -55.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.